Skip to content

ClearPoint Neuro CLPT Operating Income

Operating Income at other companies

Abbott logo
AbbottABT
$1.35B-20.6%
Boston Scientific logo
Boston ScientificBSX
$1.1B+19.5%
IAR
Integra LifeSciencesIART
$11.47M+174%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$373.2M+27.7%
Medtronic logo
MedtronicMDT
$1.87B+30.4%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$5.57M-8.2%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's operating income?
ClearPoint Neuro (CLPT) reported operating income of -$8.48M in Q1 2026.
How has ClearPoint Neuro's operating income changed year-over-year?
ClearPoint Neuro's operating income decreased by 37.6% year-over-year, from -$6.16M to -$8.48M.
What is the long-term trend for ClearPoint Neuro's operating income?
Over 4 years (2021 to 2025), ClearPoint Neuro's operating income has grown at a 15.9% compound annual growth rate (CAGR), from -$13.37M to -$24.16M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.